drugset / Trial / NCT01344538

Ginger for Colorectal Cancer Prevention

NCT01344538

Phase 2 Completed 30 enrolled University of Michigan
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine if ginger root extract when taken daily for 28 days is able to decrease levels of inflammatory chemicals called eicosanoids in the gut tissue of people who are at normal risk and those at increased of developing colorectal cancer compared to people taking placebo.

Timeline

Start
2007-04
Primary completion
2011-05
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginger Traditional medicine (herbal / TCM) 2 g Oral

Indications